Subtype
Colorectal Neoplasm
CI-CAN-00002404Explore in graph →
Non-malignant1,784 active trials21 approved drugs382 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002404Explore in graph →
Clinical trials
8,604 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05451719 | Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy | unknown | Phase 2 | 116 | Fudan UniversityOTHER | 0 | Jul 12, 2022 | clinicaltrials |
| NCT05447715 | Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer | unknown | Phase 2 | 134 | Weijian GuoOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT05440552 | Evaluation of Colorectal Cancer Screening Strategies in China | unknown | N/A | 20,000 | Shandong UniversityOTHER | 0 | Jul 1, 2022 | clinicaltrials |
| NCT05440565 | Evaluation of Different Colorectal Cancer Screening Strategies | unknown | N/A | 20,000 | Shandong UniversityOTHER | 0 | Jul 1, 2022 | clinicaltrials |
| NCT04628182 | The China Laparoscopic Right Hemicolectomy SNAPSHOT | unknown | — | 1,579 | Beijing Friendship HospitalOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT05426811 | Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients | unknown | Phase 1 / Phase 2 | 50 | China Medical University, ChinaOTHER | 0 | Jun 29, 2022 | clinicaltrials |
| NCT05438108 | SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC | unknown | Phase 2 | 30 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT03668431 | Dabrafenib + Trametinib + PDR001 In Colorectal Cancer | unknown | Phase 2 | 25 | Massachusetts General HospitalOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT04750772 | Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05412355 | Effects of Incomplete ERAS on Clinical Outcomes in Patients With Colorectal Cancer | unknown | — | 1,000 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jun 24, 2022 | clinicaltrials |
| NCT05099211 | Neuromuscular Deconditioning and Reconditioning in Colon Cancer Patients: an APA Muscle Rendorcement Program(REMUSCLON) | unknown | N/A | 60 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05369312 | Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients | unknown | Phase 1 | 230 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05423886 | The Effectiveness of Personalized Colorectal Cancer Screening Based on Fecal Hemoglobin Concentration(PERFECT-FIT) | unknown | N/A | 20,000 | Esther Toes-ZoutendijkOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05424939 | Management of Obstructive Colon Tumors in Istanbul | unknown | — | 500 | Istanbul Medipol University HospitalOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04637048 | Observational Study on Patients With Hepatobiliary Tumors | unknown | — | 1,000 | Gang Chen, MDOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05422547 | Role of Immunoscore® in Stage II-III Colorectal Cancer | unknown | — | 100 | D'Or Institute for Research and EducationOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT02588781 | Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02959541 | PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer | unknown | N/A | 48 | Vastra Gotaland RegionOTHER_GOV | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03626922 | Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients | unknown | Phase 1 | 33 | NSABP Foundation IncNETWORK | 1 | Jun 10, 2022 | clinicaltrials |
| NCT05411783 | Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial(LOTHVEIN) | unknown | N/A | 84 | San Carlo di Nancy HospitalOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT05409417 | Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status | unknown | Phase 2 / Phase 3 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT05408182 | Early Discharge After Robotic Colorectal Surgery (eRCS): a Prospective Observational Study(eRCS) | unknown | — | 100 | Ospedale di CamposampieroOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT05406206 | Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy | unknown | Phase 2 | 27 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05402124 | The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study | unknown | Phase 2 | 100 | University of CalgaryOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05387876 | Vitamin D Intervention and Associated Changes in the Gut Microbiome and Vitamin D Levels in Healthy Adults(VDMT) | unknown | N/A | 43 | Baylor UniversityOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05382377 | NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors | unknown | Early Phase 1 | 18 | jianming xuOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT03863236 | A Study of Perioperative Oral Nutritional Support for Patients Having Surgery for Colon Cancer, Peri-Nutri | unknown | N/A | 318 | University of OuluOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT04599920 | Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life) | unknown | N/A | 100 | University of HelsinkiOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT05378867 | A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC(CRC) | unknown | Phase 3 | 126 | Zhejiang Teruisi Pharmaceutical Inc.INDUSTRY | 0 | May 18, 2022 | clinicaltrials |
| NCT02494791 | Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer(LS2) | unknown | N/A | 886 | University Health Network, TorontoOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT05365256 | Impact of Virtual Reality on the Mental Health of Patients Undergoing Adjuvant Treatment for Colorectal Cancer(VIRECAPS2) | unknown | N/A | 98 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05371197 | Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer | unknown | Phase 2 | 26 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05367284 | Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer Patients(TERESA) | unknown | — | 30 | London North West Healthcare NHS TrustOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT05368051 | Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer | unknown | — | 30 | Beijing Friendship HospitalOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT05066048 | Intestinal Microecological Dysregulation Caused by Appendectomy Increases the Risk of Colorectal Cancer(IMDCBAITROCC) | unknown | — | 300 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03411707 | Multiple Screening Methods for the Detection of Chinese Colorectal Advanced Adenomatous Polyps and Cancer | unknown | — | 1,200 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT05349110 | Real-time Diagnosis of Diminutive Colorectal Polyps Using AI(COMET-OPTICAL) | unknown | — | 105 | Maastricht University Medical CenterOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05362617 | mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy | unknown | Phase 3 | 328 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT03794193 | The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer | unknown | — | 1,367 | Peking Union Medical College HospitalOTHER | 0 | May 4, 2022 | clinicaltrials |
| NCT05154474 | Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy(SPACE2) | unknown | — | 150 | WepromOTHER | 1 | May 3, 2022 | clinicaltrials |
| NCT02562963 | Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 120 | Minghui ZhangOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT05353582 | Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases | unknown | Phase 2 | 168 | Sun Yat-sen UniversityOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT05354817 | Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin(Re-Play) | unknown | Phase 2 | 25 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT03009227 | Study of Oncological Outcomes of D3 Lymph Node Dissection in Colon Cancer(COLD) | unknown | N/A | 780 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT03868605 | Endoscopic Full Thickness Resection Versus Standard Therapy of the Colorectal Neoplasia | unknown | N/A | 80 | Military University Hospital, PragueOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT05333809 | Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 0 | Apr 20, 2022 | clinicaltrials |
| NCT05334251 | General Anesthesia or Combined Spinal-epidural Anesthesia With Ketofol Sedation in Colon Cancer Surgery? | unknown | — | 60 | Ankara City Hospital BilkentOTHER | 0 | Apr 19, 2022 | clinicaltrials |
| NCT05335460 | To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer | unknown | Phase 2 | 36 | Fujian Cancer HospitalOTHER_GOV | 0 | Apr 19, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jul 12, 2022source: clinicaltrials